Glioma imaging in Europe. A survey of 220 centres and recommendations for best clinical practice
Creators
- 1. University College London Hospital, Imaging Department, London (United Kingdom)
- 2. UCL Institute of Neurology, Department of Brain Rehabilitation and Repair, London (United Kingdom)
- 3. Lysholm Neuroradiology Department, National Hospital for Neurology and Neurosurgery, London (United Kingdom)
- 4. University Hospital Heidelberg, Department of Neuroradiology, Heidelberg (Germany)
- 5. San Raffaele Scientific Institute, Department of Neuroradiology, Milan (Italy)
- 6. University of Edinburgh, Neuroimaging Sciences, Edinburgh (United Kingdom)
- 7. Skaane University hospital, Centre for Imaging and Physiology, Lund (Sweden)
- 8. Lund University, Institution for Clinical Sciences/Radiology, Lund (Sweden)
- 9. University of Athens, Athens (Greece)
- 10. Central Clinic of Athens, Athens (Greece)
- 11. General Anti-Cancer and Oncological Hospital ''Agios Savvas'', Athens (Greece)
- 12. Hospital 12 de Octubre, Madrid (Spain)
- 13. Institut per la Recerca Biomedica August Pi i Sunyer (IDIBAPS), Magnetic Resonance Core Facility, Barcelona (Spain)
- 14. Hospital Clinic de Barcelona, Image Diagnostic Centre, Barcelona (Spain)
- 15. Erasmus MC, Department of Epidemiology, Rotterdam (Netherlands)
- 16. Erasmus MC, Department of Radiology and Nuclear Medicine, Rotterdam (Netherlands)
Description
At a European Society of Neuroradiology (ESNR) Annual Meeting 2015 workshop, commonalities in practice, current controversies and technical hurdles in glioma MRI were discussed. We aimed to formulate guidance on MRI of glioma and determine its feasibility, by seeking information on glioma imaging practices from the European Neuroradiology community. Invitations to a structured survey were emailed to ESNR members (n=1,662) and associates (n=6,400), European national radiologists' societies and distributed via social media. Responses were received from 220 institutions (59% academic). Conventional imaging protocols generally include T2w, T2-FLAIR, DWI, and pre- and post-contrast T1w. Perfusion MRI is used widely (85.5%), while spectroscopy seems reserved for specific indications. Reasons for omitting advanced imaging modalities include lack of facility/software, time constraints and no requests. Early postoperative MRI is routinely carried out by 74% within 24-72 h, but only 17% report a percent measure of resection. For follow-up, most sites (60%) issue qualitative reports, while 27% report an assessment according to the RANO criteria. A minority of sites use a reporting template (23%). Clinical best practice recommendations for glioma imaging assessment are proposed and the current role of advanced MRI modalities in routine use is addressed. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00330-018-5314-5Additional details
Identifiers
Publishing Information
- Journal Title
- European Radiology
- Journal Volume
- 28
- Journal Issue
- 8
- Journal Page Range
- p. 3306-3317
- ISSN
- 0938-7994
- CODEN
- EURAE3
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 49076188
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BRAIN; CONTRAST MEDIA; DIFFUSION; EUROPE; GLIOMAS; IMAGE PROCESSING; MAGNETIC SUSCEPTIBILITY; MEETINGS; METABOLITES; MONITORING; NEOPLASMS; NMR IMAGING; NMR SPECTRA; RECOMMENDATIONS; RELAXATION TIME; REVIEWS; SPIN ECHO; SURGERY; THERAPY; WEIGHTING FUNCTIONS
- Descriptors DEC
- BODY; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC TECHNIQUES; DISEASES; DOCUMENT TYPES; FUNCTIONS; MAGNETIC PROPERTIES; MEDICINE; NEOPLASMS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; ORGANS; PHYSICAL PROPERTIES; PROCESSING; SPECTRA